航天医学与医学工程

[1]HE Dacheng,XIAO Xueyuan.Differential proteome andits application[J].The Academic Journal of Peking Nor-mal University(nature),2002,38(4):558-562.

[2]LI Cui,XIAO Zhiqiang,CHEN Zhuchu,et al.Proteomeanalysis of human lungs quamous carcinoma[J].Pro-teomics,2006,6(2):547-558.

[3]FUJIIK,NAKANOT,KANAZAWAM,et al.Clinical-scale-high throughput human plasma proteome analysis:lungadenocanoma[J].Proteomics,2005,5(4):1150-1159.

[4]Maja Puchades,Sara Folkesson Hansson,Carol L.Nils-son,et al.Proteomic studies of potential cerebrospinalfluid protein markers for Alzheimer’s disease[J].Mo-lecular Brain Research,2003,118(1-2):140-146.

[5]MING Jiang,LIN ZhiJia,WEI Huajiang,et al.Protein dis-regulation in red blood cell membranes of type 2 diabetic pa-tients[J].Biochemical and Biophysical Research Communica-tions,2003,309(1):196-200.

[6]Antoon JVB,Abdoelwaheb EG,Hensbergen PJ,et al.Differ-ential expression of CRABP-II in fibroblasts derived fromdermis and subcutaneous fat[J].Biochemical and Bio-physical Research Communications,2004,315(2):428-433.

[7]HOU Shu,HU Lin-sen,CHAN Ming,et al.Proteomicresearch of early differentiation induced by NGFinPC12cells using DIGE system and MALDI-TOFM[J].Journalof Apoploxy and Nervous Diseases,2006,123(1):52-55.

[8]XU Hui,CHANG Ming,ZHANG Lei,et al.The expres-sion of glucose regulating protein78in amodel of Parkin-son’s disease induced by6-Hydroxy dopamine in PC12cells[J].J Apoplexy and Nervous Diseases,2007,14(2):154-156.

[9]Giddings C.Concepts and comparisons in multi-dimen-sional separation[J].J High Resolut,Chromtogr,Com-mun,1987,10(10):319-323.

[10]ZHANG Weibing,MENG Fanqiong,ZHANG Qinghe.Application of multidimensional liquid chromatographytandem mass spectrometry in the analysis of bioactivepeptides derived from pig blood hydrolyzed by pepsin[J].Chinese Journal of Analysis Laboratory,2006,25(10):36-39.

[11]David KH,Eng J,Zhou H,et al.Quantitative profiling ofdifferentiation induced microsomal proteins using iso-tope-coded affinity tags and mass spectrometry[J].Nat Biotechnol,2001,19(10):946-951.

[12]Griffin TJ,Gygi SP,Rist B,et al.Quantitative proteomicanalysis using a MALDI quadrupole time-of-flight massspectrometer[J].Anal Chem,2001,73(5):978-986.

[13]Michael GB,Conrads TP,Panisko EA,et al.Phospho-protein isotope-coded affinity tag approach for isolatingand quantitating phosphor-peptides in proteome-wideanalyses[J].Anal Chem,2001,73(11):2578-2586.

[14]Zhou H,Ranish JA,Watts JD,et al.Quantitative pro-teome analysis by solid phase isotope tagging and massspectrometry[J].NatBiotechnol,2002,20(5):512-515.

[15]Hardt M,Witkowska HE,Webb S,et al.Assessing theeffects of diurnal variation on the composition of humanparotidsaliva:quantitative analysis of native peptides u-sing iTRAQ reagents[J].Anal Chem,2005,77(15):4947-4954.

[16]CONG Yusheng,FAN Elle E,WANG Eugenia.Simulta-neous proteomic profiling of four different growth statesof human fibroblasts,using amine reactive isobaric tag-ging reagents and tandem mass spectrometry[J].Mech Ageing Dev,2006,127(4):332-343.

[17]LI Wei.The application of iTRAQ multi-chemical markedtandem mass technology in the differencial proteome[J].Life Chemistics,2006,26(5):453-456.

[18]Ross PL,Huang YN,Marchese JN,et al.Multiplexedprotein quantitation in Saccharomyces cerevisiae usingamine reactive isobaric tagging reagents[J].Mol CellProteomics,2004,3(12):1154-1169.

[19]Wu WW,Wang G,Baek SJ,et al.Comparative studyof three proteomic quantitative methods,DIGE,cICAT,and iTRAQ,using2D Gel or LC MALDI TOF/TOF[J].JProteome Res,2006,5(3):651-658.

[20]Smolka MB,Zhou H,Purkayastha S,et al.Optimizationof the isotope-coded affinity tag-labeling procedure forquantitative proteome analysis[J].Anal Biochem,2001,297(1):25-31.

[21]Leroi Desouza,Georg Diehl,Mary Joe Rodrigues,et al.Search for cancer markers from endometrial tissues u-sing differentially labeled tags iTRAQ and cICAT withmultidimensional liquid chromatography and tandemmass spectrometry[J].J Proteome Res,2005,4(2):377-386.

[22]Petricoin E,Ardekani AM,Hitt BA,et al.The use of pro-teomic patterns in serum to identify ovarian cancer[J].The Lancet,2002,359:572.

[23]WU Weiguo,TANG Ximing,HU Wei,et al.Identifica-tion and validation of metastasis-associated protein headand neck cancer cell lines by two-dimensional electro-phoresis and mass spectrometry[J].Clin Exp Metasta-sis,2002,19(4):319-326.

[24]Paul G,Gallaghera,Yong de Baoa,et al.Use of micro-arrays for investigating the sub-toxic effects of snakevenoms:insights into venom-induced apoptosis in hu-man umbilical vein endothelial cells[J].Toxicon,2003(41):429-440.

[25]Petricoin EF,Liotta LA.SELDI-TOF-based serum pro-teomic pattern diagnostics for early detection of cancer[J].Curr Opin Biotechnol,2004,15(1):24-30.

[26]Conrads TP,Hood BL,Issaq HJ,et al.Proteomic pat-terns as a diagnostic tool for early stage cancer:a re-view of its progress to a clinical relevant tool[J].MolDiagn,2004,8(2):77-85.

[27]Li J,Zhang Z,Rosenzweig J,et al.Proteomics and biofor-matics approaches for identification of serum biomarker to de-tect breast cancer[J].Clin Chem,2002,48(8):1296-1304.

[28]DAI Songwei,WANG Xiaomin,LIULiyun,et al.Discoveryand identification of serum Amyloid Aprotein elevated in lungcancer serum[J].Sci China C life Sci,2007,50(3):305-311.

[29]ZHANG Linqi,YU Wenjie,HE Tian,et al.Contribution ofhuman alpha-defensin and the anti-HIV activity of CD8antiviral factor[J].Science.2002,298(59):995-1000.

[30]Rosty C,Christa L,Kuzdzal S,et al.Identification ofhepatocarcinoma intestine pancreas pancreatitis associ-ated protein I as a biomarker for pancreatic ductal ade-nocarcinoma by protein biochip technology[J].CancerRes,2002,62(6):1868-1875.

[31]Poon TC,Yip TT,Chan AT,et al.Comprehensive pro-teomic profiling identifies serum proteomic signaturesfor detection of hepatocellular carcinoma and its sub-types[J].Clin Chem,2003,49(5):752-760.

[32]SUN Ling,BAI Jie,CHEN Shiling.Surface/enhanced la-ser desorption/ionization time-of-flight mass spectrom-etry for proteomic analysis of seminal plasma in patientswith delayed semen liquid faction[J].J South MedUniv,2007,27(4):442-444.

[33]George S.P1filamentous fusion phage:novel expres-sion vector that display cloned antigens on the viron sur-face[J].Science,1985,228(4705):1315-1317.

[34]Scott J K,Smith G.P1searching for peptide ligandswith an epitope library[J].Science,1990,246(4967):386-390.

[35]JU Lizhong,ZHONG Yanwei,ChENG Jun,et al.Thepromoter DNA binding protein of the anti-activated geneHCTP4of the core protein of hepatitis virus C werescreened by phage display technology[J].Journal ofLiver Disease of Traditional Chinese and Western Medi-cine,2003,13(6):360-362.

[36]YANG Yanjie,CHENG Jun,CHEN Dongfeng,et al.ThepromoterⅡbinding protein of the anti-activated geneHCTP4of the core protein of hepatitis virus B werescreened by phage display technology[J].MedicalJournal of Chinese People’s Liberation Army,2004,29(1):3-26.

[37]XIE Jianping,LE Jun,WANG Honghai.The searching ofmicrobe genes with unknown function appropritating forhigh-flux drug target screening[J].Life Chemistry,2002,22(1):84-86.

[38]WANG Defa,LIU Chenghu,QIAO Huan,Gene cloningand screening of single stranded antibody of breastcancer by phage display technology[J].The AcademicJournal of Nan-kai University,2004,37(1):88-91.

[39]Ricolleau G,Charbonnel C,Lode L,et al,Surface-en-hanced laser desorption/ionization time of flight massspectrometry protein profiling identifies ubiquitin and fer-ritin light chain as prognostic biomarkers in node-nega-tive breast cancer tumors[J].Proteomics,2006,6(6):1963-1975.

[40]Mikhailichenko VV,Esipov AS,Peculiarities of semencoagulation and liquefaction in males from infertile cou-ples[J].Fertil Sterl,2005,84(1):256-259.

[41]YUE Yong,YAO Yongjie,SUN Xiqing.Weightlessnessor weighlessness simulation and vascular remodeling[J].Space Medicine&Medical Engineering,2003,16(2):152-156.

[42]YUE Yong,YAO Yongjie,XIE Xiaoping,et al.Effects ofsimulated weightlessness on pressure volum evelationships of femoral vein of newzealand rabbits[J].SpaceMedicine&Medical Engineering,2002,15(6):410-414.